HUMA Earnings

Quarterly EPS
$-0.33
Q3 2024
$-0.16
Q4 2024
$0.28
Q1 2025
$-0.24
Q2 2025
$-0.11
Q3 2025
$-0.13
Q4 2025
$-0.09
Q1 2026
$-0.16
Q2 2026
Latest Revenue406.0K
Latest Net Income-36802000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.16406.0K-36802000+34.9%+33.3%
Q1 2026-$0.09495.0K-17619000-4.3%-132.1%
Q4 2025-$0.13467.0K-24804000+18.8%
Q3 2025-$0.11753.0K-17510000+66.7%
Q2 2025-$0.24301.0K-37658000+50.0%
Q1 2025$0.28517.0K39.1M+196.6%
Q4 2024-$0.160-20940000+33.3%
Q3 2024-$0.330-39202000-32.0%
Q2 2024-$0.480-56663000
Q1 2024-$0.290-31896000
Q4 2023-$0.240-25106000
Q3 2023-$0.250-25995000
Humacyte (HUMA) — Earnings